Stocks
Heron Therapeutics (HRTX) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -7.71 | -7.81 | -4.19 | -1.95 | -3.22 | -9.44 | ||
| Changes by years, y/y, % | -10% | +1% | -46% | -53% | +65% | -17.7% | |||
Heron Therapeutics. EV/EBITDA
Heron Therapeutics. EV/EBITDA, changes, %
Heron Therapeutics (HRTX) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -2.13 | -3.36 | -6.81 | -15.5 | -18.5 | -9.44 | |
| Changes by years, y/y, % | -12% | +56% | +251% | +705% | +768% | |||
| Changes by quarters, q/q, % | +10% | +57% | +103% | +128% | +19% | |||
